Open Access

HOW I DO IT

How I Do It: Optilume BPH catheter system

Dean S. Elterman¹, Bruce Gao¹, Kevin C. Zorn², Naeem Bhojani², Alexis Te³, Bilal Chughtai³, Steven A. Kaplan

1 Division of Urology, Department of Surgery, University of Toronto, Ontario, Canada
2 Division of Urology, Centre hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada
3 Department of Urology, Weill Cornell Medical College-New York Presbyterian, New York, New York, USA
4 Icahn School of Medicine at Mount Sinai, New York, New York, USA
Address correspondence to Dr. Dean S. Elterman, Division of Urology, Department of Surgery, University of Toronto, 399 Bathurst Street, MP-8-317, Toronto, ON M5T 2S8 Canada

Canadian Journal of Urology 2023, 30(3), 11568-11573.

Abstract

Benign prostatic hyperplasia (BPH) is a common and progressive disease affecting aging men which has a significant impact on quality of life. The Optilume BPH Catheter System (Optilume BPH) is a prostatic dilation system that combines balloon dilation with a localized transfer of paclitaxel to maintain long term patency. Optilume BPH can be deployed using standard rigid cystoscopy without general anesthesia in an office setting. Prospective data indicate that Optilume BPH has favorable functional and sexual patient outcomes. Readers will familiarize themselves with Optilume BPH, significant historical studies and the technique for deploying Optilume BPH.

---

Keywords

---